Learn more

NVENTA BIOPHARMACEUTICALS CORP

Overview
  • Total Patents
    32
About

NVENTA BIOPHARMACEUTICALS CORP has a total of 32 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are CISTEM BIOTECHNOLOGIES GMBH, ADISTEM LTD and OZAWA KEIYA.

Patent filings per year

Chart showing NVENTA BIOPHARMACEUTICALS CORPs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Emtage Peter 19
#2 Siegel Marvin 15
#3 Webb John 8
#4 Rowse Gerry 8
#5 Mizzen Lee 4
#6 Winnett Mark 3
#7 Goldstone Stephen 3
#8 Neefe John 3
#9 Winnett Mark T 2
#10 Neefe John R 2

Latest patents

Publication Filing date Title
WO2010054482A1 Immunogenic human papillomavirus compositions
WO2009086640A1 Adjuvant compositions comprising poly-ic and a cationic polymer
CA2680060A1 Double-stranded locked nucleic acid compositions
WO2007137427A1 Bioactive purified hspe7 compositions
AU2005201826A1 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
AU2001271449B2 Human papilloma virus treatment